Effentora

Effentora is a buccal film containing fentanyl citrate, used for managing breakthrough pain in adults already on opioid therapy. This fast-acting medication is designed for oral mucosal application.

Effentora is primarily used for the management of breakthrough pain in adults who are already receiving opioid therapy for chronic pain. The buccal film is applied to the inner lining of the cheek, where it dissolves to deliver fentanyl citrate for rapid pain relief. This medication is not intended for initial pain management or for use in opioid-naive patients.

Common effects of Effentora may include drowsiness, dizziness, nausea, and headache. Some users may experience dry mouth or constipation. These effects are generally mild and transient, but severe or persistent symptoms should be discussed with a healthcare provider.

Effentora should be handled with care to avoid accidental exposure, especially to children. It is important to follow the prescribed dosage and administration instructions. The medication should be stored securely and disposed of properly to prevent misuse. Patients should be aware of the risks of respiratory depression and sedation.

Effentora may interact with other medications, including central nervous system depressants like alcohol, benzodiazepines, and other opioids. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Combining Effentora with CYP3A4 inhibitors can increase the risk of side effects.